Michel Vounatsos
Director/Board Member en REVVITY, INC. .
Fortuna: 15 M $ al 31/03/2024
Perfil
Michel Vounatsos es miembro del consejo de administración de PerkinElmer, Inc. (Estados Unidos), LInstitut de RYthmologie et Modlisation Cardiaque y n-Lorem Foundation, y director general y consejero de Biogen, Inc. En su anterior carrera ocupó el cargo de Presidente de la Línea de Negocio de Atención Primaria y Clientes en Merck & Co. El Sr. Vounatsos obtuvo un MBA en la Escuela de Altos Estudios Comerciales de París.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
BIOGEN INC.
0.05% | 28/04/2023 | 67 262 ( 0.05% ) | 15 M $ | 31/03/2024 |
REVVITY, INC.
0.01% | 15/05/2023 | 6 486 ( 0.01% ) | 681 030 $ | 31/03/2024 |
ZAI LAB LTD.
0.02% | 30/06/2023 | 183 320 ( 0.02% ) | 302 159 $ | 31/03/2024 |
Cargos activos de Michel Vounatsos
| Empresas | Cargo | Inicio |
|---|---|---|
| REVVITY, INC. | Director/Board Member | 01/03/2020 |
| ZAI LAB LIMITED | Director/Board Member | 07/01/2023 |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Chief Executive Officer | 06/01/2017 |
Biogen GmbH
 Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The private company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | Chief Executive Officer | - |
| L’Institut de RYthmologie et Modélisation Cardiaque | Chairman | - |
| n-Lorem Foundation | Director/Board Member | - |
Revvity BV
 Revvity BV Medical SpecialtiesHealth Technology PerkinElmer focuses on improving the health and safety of people and the environment. The company is headquartered in Zaventem, Belgium. | Director/Board Member | - |
Antiguos cargos conocidos de Michel Vounatsos.
| Empresas | Cargo | Fin |
|---|---|---|
| BIOGEN INC. | Chief Executive Officer | 14/11/2022 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/04/2016 |
Formación de Michel Vounatsos.
| École des Hautes Études Commerciales de Paris | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| REVVITY, INC. | Health Technology |
| ZAI LAB LIMITED | Health Technology |
| Empresas privadas | 5 |
|---|---|
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Health Technology |
Revvity BV
Revvity BV Medical SpecialtiesHealth Technology PerkinElmer focuses on improving the health and safety of people and the environment. The company is headquartered in Zaventem, Belgium. | Health Technology |
| L’Institut de RYthmologie et Modélisation Cardiaque | |
| n-Lorem Foundation | |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The private company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | Health Technology |
- Bolsa de valores
- Insiders
- Michel Vounatsos
